In conclusion, the ephrinB1/ERBB2 (in breast cancer) and ephrinB1/ERBB1 (in head and neck cancer) complexes induce MAPK pathway activation and are positively regulated by SRC and negatively regulated by PTPN13. This evidence concerns the gene ERBB2 and breast cancer.